https://wiki.tiffa.net/w/index.php?action=history&feed=atom&title=Translations%3ALipid-lowering_agent%2F7%2FenTranslations:Lipid-lowering agent/7/en - Revision history2026-09-11T13:15:21ZRevision history for this page on the wikiMediaWiki 1.43.0https://wiki.tiffa.net/w/index.php?title=Translations:Lipid-lowering_agent/7/en&diff=138956&oldid=prevFuzzyBot: Importing a new version from external source2024-04-13T12:44:41Z<p>Importing a new version from external source</p>
<p><b>New page</b></p><div>==Research==<br />
Investigational classes of hypolipidemic agents:<br />
* [[CETP inhibitor]]s (cholesteryl ester transfer protein), 1 candidate is in trials. ([[Anacetrapib]]) It is expected that these drugs will mainly increase HDL while lowering LDL<br />
* [[Squalene synthase inhibitor]]<br />
* [[ApoA-1 Milano]]<br />
* Succinobucol (AGI-1067), a novel antioxidant, failed a phase-III trial.<br />
* Apoprotein-B inhibitor [[mipomersen]] (approved by the FDA in 2013 homozygous [[familial hypercholesterolemia]].).<br />
* [[Bempedoic acid]], an ATP citrate lyase inhibitor</div>FuzzyBot